vTv Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
vTv Therapeutics Inc. (VTVT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $2.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-03-10
- vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $2.90M, a 0.00% change from fiscal 2024.
- vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $2.90M, a 31.82% increase from fiscal 2023.
- vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $2.20M, a 46.67% increase from fiscal 2022.
- vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $1.50M, a 28.57% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|
| 2025-12-31 | $2.90M 10-K · filed 2026-03-10 |
| 2024-12-31 | $2.90M 10-K · filed 2026-03-10 |
| 2023-12-31 | $2.20M 10-K · filed 2026-03-10 |
| 2022-12-31 | $1.50M 10-K · filed 2025-03-20 |
| 2021-12-31 | $2.10M 10-K · filed 2024-03-13 |